New Market Research Report: Qatar Pharmaceuticals & Healthcare Report Q4 2015

The roll out of Qatar's mandatory health insurance scheme will provide commercial opportunities for private healthcare providers, drugmakers, and medical devices and infrastructure companies. Expansion projects are already underway and in the pipeline in a bid to take advantage of the rapidly increasing demand for healthcare services.

Headline Expenditure Projections

Pharmaceuticals: QAR1.79bn (USD491mn) in 2014 to QAR2.00bn (USD548mn) in 2015; +11.5% in local currency and US dollar terms. Forecast downgrad ed from Q 3 15.
Healthcare: QAR17.25bn (USD4.74bn) in 2014 to QAR18.86bn (USD5.19bn) in 2015; +9.3% in both local currency and US dollar terms. Forecast in line with Q 3 15 .

Risk/Reward Index

Qatar's risks are particularly low in comparison with the rest of the Middle East and Africa (MEA) region, although its potential rewards are dampened by the small market size. Nevertheless, Qatar's high level of urbanisation, rapid population growth and rising prevalence of chronic lifestyle diseases creates an environment in which there is strong potential for market growth. In BMI's Pharmaceutical Risk/Reward Index for the MEA matrix in Q415, Qatar has retained its position in the MEA matrix of fourth place, with the country's score this remaining at 55.5 out of 100.

Full Report Details at
- http://www.fastmr.com/prod/1047970_qatar_pharmaceuticals.aspx?afid=301

Key Trends and Developments

It was reported in June 2015 that health centres under the Primary Health Care Corporation (PHCC) in Qatar recorded more than 5mn visits between April 1 2014 and March 31 2015. The PHCC also recorded in excess of 1mn new registrations during 2014/15.

The Qatar Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Qatar Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Qatar pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Qatar, to test other views - a key input for successful budgeting and strategic business planning in the Qatari pharmaceutical and healthcare market.
* Target business opportunities and risks in the Qatari pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Qatar.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Bahrain Pharmaceuticals & Healthcare Report Q4 2015
- Romania Pharmaceuticals & Healthcare Report Q4 2015
- Bulgaria Pharmaceuticals & Healthcare Report Q4 2015
- Peru Pharmaceuticals & Healthcare Report Q4 2015
- Latvia Pharmaceuticals & Healthcare Report Q4 2015